Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in Tourette syndrome patients.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Finasteride may help reduce tic severity in male Tourette syndrome patients.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in patients with Tourette syndrome.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

The review emphasizes the need to recognize skin conditions that affect hair follicles and sweat glands to avoid misdiagnosis.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

Skin grafting can help repigment vitiligo, but it's less effective for widespread cases due to the Koebner phenomenon.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

Tamoxifen caused hair loss in a 52-year-old woman.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.